Sangamo Therapeutics
SGMO
#8725
Rank
โ‚น14.99 B
Marketcap
โ‚น44.55
Share price
-6.45%
Change (1 day)
-73.30%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -โ‚น9.46 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚น32.87 Million. In 2024 the company made an earning of -โ‚น8.85 Billion, an increase over its 2023 earnings that were of -โ‚น10.69 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น9.46 Billion6.86%
2024 -โ‚น8.85 Billion-17.27%
2023 -โ‚น10.69 Billion-40.88%
2022 -โ‚น18.09 Billion9.79%
2021 -โ‚น16.48 Billion41.52%
2020 -โ‚น11.64 Billion23.17%
2019 -โ‚น9.45 Billion36.33%
2018 -โ‚น6.94 Billion36.89%
2017 -โ‚น5.07 Billion-22.32%
2016 -โ‚น6.52 Billion54.86%
2015 -โ‚น4.21 Billion75.62%
2014 -โ‚น2.4 Billion0.13%
2013 -โ‚น2.4 Billion
2011 -โ‚น3.22 Billion43.66%
2010 -โ‚น2.25 Billion28.52%
2009 -โ‚น1.75 Billion-23.55%
2008 -โ‚น2.28 Billion2.45%
2007 -โ‚น2.23 Billion19.5%
2006 -โ‚น1.87 Billion50.78%
2005 -โ‚น1.24 Billion75%
2004 -โ‚น0.71 Billion-33.25%
2003 -โ‚น1.06 Billion-62.27%
2002 -โ‚น2.81 Billion102.82%
2001 -โ‚น1.39 Billion23.21%
2000 -โ‚น1.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚น888.12 B-9,167.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น11.70 B-219.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น740.61 B-7,661.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น171.04 B-1,846.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚น66.84 Billion 582.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.910 T-29,814.01%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น61.02 B-723.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.074 T-21,278.43%๐Ÿ‡บ๐Ÿ‡ธ USA